Where are Pharma Companies in the Age of Artificial Intelligence?
They say good things come to those who wait; we say good things come to those who wait but only the things left by the visionaries before them. The pharmaceutical industry has long been known to lag in the adoption of new technology due to strong regulations. Even though regulators have recently begun to open up to several new ‘big data’ or pharma 4.0 technologies - the question remains, if pharma companies are doing the same? In 2016, the European Pharmacopoeia 9.0 in Chapter 5.21 announced that neural networks (NN) and support vector machines (SVM) are valid chemometric techniques for processing analytical data sets.
Cultural Resistance… Who are the Real Enablers?
Advanced analytics technologies in the pharmaceutical industry are accessible now more than ever and regulators have slowly become more accepting of these kinds of advances. The introduction of machine learning, artificial intelligence, and big data technologies are disrupting our industry, and it’s time we change our mindset.